Brexit Who? Europe Forges Ahead with $1.8 Billion Investment in 3Q16 Pharmaceutical-Biotech Construction Project Starts

SUGAR LAND--July 11, 2016--Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas)--While politicians and pundits debate the impact of Brexit (Britain's exist from the European Union) on just about everything, for now, it is business as usual in terms of imminent project starts for the Pharmaceutical-Biotech Industry in Europe. The region has $1.8 billion worth of reported capital and MRO (maintenance, repairs and operations) projects set to launch during the third quarter of this year.

Within this article: Lists three pharma projects kicking off in the third quarter that Industrial Info is tracking.